KRMD insider disclosures
Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source | Follow |
|---|---|---|---|---|---|---|---|
Joint filing · 4 reporting ownersKORU Medical Systems, Inc. | KRMD KORU Medical Systems, Inc. | Other transactionFiling detailsSEC transaction code J Common Stock · Indirect ownership · By Horton Capital Partners Fund, LP · Reported balance after transaction: 5031452 · See Exhibit 99.1 to this Form 4 for explanation of note (1). · See Exhibit 99.1 to this Form 4 for explanation of note (2). · The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. | 2026-11-20 | 2026-11-20 | 43,208 shares/units | SEC 4 | From owner profile |
| Schiller Eric Chief Technology Officer · KORU Medical Systems, Inc. | KRMD KORU Medical Systems, Inc. | BuyFiling detailsSEC transaction code P Common Stock · Direct ownership · Reported balance after transaction: 13546.09 · SEC code covers open-market or private transactions · The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed. | 2026-11-13 | 2026-11-17 | ≈ $31,022.31 8,546.09 shares/units | SEC 4 | Follow |
Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.